We have identified four particular areas of expertise, shown in the diagram below. As at 31 July 2015, the value of the top 20 investments in our portfolio stood at £292.3 million while our total portfolio was valued at £327.2 million.
A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies
Using Xenon to prevent neuronal damage
Internet of Things solutions provider specialising in fully integrated business solutions around connected product intelligence.